However, the amount of Covid vaccines to be exported will likely be determined by the federal government each month to guarantee there isn’t a dearth of home availability.
India not too long ago resumed Covid vaccine provide to the UN-backed COVAX with the federal government permitting Serum Institute of India (SII) to export 50 Lakh doses of Covishield to Nepal, Tajikistan, Bangladesh and Mozambique.
The Covishield cargo will attain Nepal and Tajikistan this week.
“More than 22.72 crore balance and unutilized COVID-19 vaccine doses are still available with the states and Union Territories. The vaccine production is increasing and there will be surplus supplies.
“Keeping this in thoughts, a call has been taken to permit commercial export of Covishield and Covaxin,” an official source told PTI.
Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII had recently communicated to the Union Health Ministry that the Pune-based firm has 24,89,15,000 doses of Covishield and the stock is increasing every day.
The official, however stressed, “The amount of vaccines to be exported will likely be determined by the federal government on a month-to-month foundation to be sure that home availability isn’t hampered in any means.”
About 31 crore doses of Covishield and Covaxin are expected to be received by the government from SII and Bharat Biotech in December, while Zydus Cadila is likely to supply around two crore jabs of its three-dose Covid vaccine ZyCoV-D by that time.
The government recently permitted the export of 2 crore doses of COVID-19 vaccine Covovax, produced in India by SII, to Indonesia. The jab is yet to be approved for emergency use in the country, according to official sources.
The first shipment of Covovax will reach Indonesia this week.